by Eric Christianson | Apr 12, 2023 | Endocrine Medication and Disease State Clinical Pearls
It is theorized that patients who are taking a GLP-1 agonist are at a greater risk for pancreatitis due to the medication causing an increase in stimulation of GLP-1 receptors located in the pancreas. This could lead to an overgrowth or overactivation of pancreatic...
by Eric Christianson | Apr 9, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Bempedoic acid, also known as Nexletol, is a once-daily medication used in patients with increased atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia who are requiring additional LDL-C lowering previously on a maximally...
by Eric Christianson | Mar 29, 2023 | Infectious Disease and Oncology Case Studies, Neurology, Pain, and Musculoskeletal Case Studies
I stumbled into this case about Valtrex neurotoxicity on Linked In, and am so thankful that Kristin Speer, PharmD, BCPS let me share it. A physician attached a message for the care team to review: “Patient continues with dizziness, hallucinations, and...
by Eric Christianson | Mar 8, 2023 | Endocrine Medication and Disease State Clinical Pearls
I know some folks out there really like crossword puzzles, so I figured why not combine a little fun with a little pharmacology education? I’ve created a free pharmacology crossword puzzle that you should be able to work through below. I didn’t make it...
by Eric Christianson | Feb 8, 2023 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Attention Deficit Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children, occurring almost twice as often in boys compared to girls. The most observed symptoms are inattention, hyperactivity, and impulsivity, but the primary...
